Hepatocellular carcinoma (HCC) is one of the most fatal malignancies. Epigenetic mechanisms have revealed that noncoding RNAs ...

A new study shows that a biomedical tool can successfully deliver genetic material to edit faulty genes in developing fetal ...

Researchers are exploring a new mRNA delivery technique to treat genetic conditions in the fetal brain, potentially ...

A new vaccine provides hope for treating and even preventing the highly contagious and difficult-to-treat Clostridioides ...

The discovery of the first mRNA-stabilizing substance could pave the way for groundbreaking advancements in the development ...

Everest Medicines’ Nefecon achieved 167 million yuan in sales in just over a month after its launch, showing its future big ...

Researchers are developing what they hope will be the first successful vaccine against the highly contagious and difficult-to ...

A year after the first samRNA vaccine approval, experts say others are likely to face scientific and regulatory hurdles.

An 800% increase in licensing deal values indicates growing confidence in mRNA technology, but some vaccine producers are ...

An mRNA vaccine, a cousin to the COVID vaccines that blunted the pandemic, has entered human trials as a treatment for lung ...

On Thursday, Moderna Inc (MRNA) stock saw a decline, ending the day at $52.8 which represents a decrease of $-0.59 or -1.11% from the prior close of $53.39. The stock opened at $53.39 and touched a ...

We recently looked at Goldman Sachs’ List Of Stocks That Hedge & Mutual Funds Love & Hate: 28 Stocks On The Mutual and Hedge ...